Chronic myeloid leukemia (CML) occurs in hematopoietic stem cells and is characterized by the presence of the BCR–ABL1 fusion gene on the Philadelphia chromosome. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.